Skip to main content
. 2017 Aug 10;16(4):4784–4790. doi: 10.3892/mmr.2017.7213

Figure 1.

Figure 1.

Immunohistochemical expressions compaired with PDX and patient tumor. The pathological characteristics of the third passage PDX xenograft was in accordance with the original patient sample. PDX, patient-derived xenograft; H&E, hematoxylin and eosin.